These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2972089)
1. Platelet activity during acute myocardial infarction treated with tissue plasminogen activator. Ring ME; Feinberg WM; Bruck DC; Butman SM Thromb Res; 1988 Aug; 51(3):331-4. PubMed ID: 2972089 [No Abstract] [Full Text] [Related]
2. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873 [TBL] [Abstract][Full Text] [Related]
3. Time course of platelet alpha granule release in acute myocardial infarction treated with streptokinase. Frandsen NJ; Winther K; Pedersen F; Christiansen I; McNair P Heart; 1996 Feb; 75(2):141-4. PubMed ID: 8673751 [TBL] [Abstract][Full Text] [Related]
4. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. Waller BF; Rothbaum DA; Pinkerton CA; Cowley MJ; Linnemeier TJ; Orr C; Irons M; Helmuth RA; Wills ER; Aust C J Am Coll Cardiol; 1987 Apr; 9(4):785-801. PubMed ID: 2951422 [TBL] [Abstract][Full Text] [Related]
5. Streptokinase, but not tissue plasminogen activator, attenuates platelet aggregation in patients with acute myocardial infarction. Karlberg KE; Chen J; Hagerman I; Bergström K; Wallin R; Saldeen T; Sylvén C J Intern Med; 1993 Nov; 234(5):513-9. PubMed ID: 8228797 [TBL] [Abstract][Full Text] [Related]
6. Platelet function after in vivo and in vitro treatment with thrombolytic agents. Bertolino G; Noris P; Previtali M; Gamba G; Ferrario M; Montani N; Balduini CL Am J Cardiol; 1992 Feb; 69(5):457-61. PubMed ID: 1736606 [TBL] [Abstract][Full Text] [Related]
7. Thrombolysis, streptokinase, and TPA in the treatment of acute myocardial infarction. Mock MB; Chesebro JH Cardiovasc Clin; 1987; 18(1):247-57. PubMed ID: 2955892 [No Abstract] [Full Text] [Related]
8. Recombinant tissue-type plasminogen activator as a thrombolytic agent in acute myocardial infarction. Parr KL; Valentine RP; Pitts DE; Schumacher RR; Schmidt PE; Brooks-Brunn JA; Ramsden C Indiana Med; 1987 May; 80(5):460-1. PubMed ID: 2953781 [No Abstract] [Full Text] [Related]
9. New developments in the treatment of acute myocardial infarction (III). Papapietro SE; Arciniegas JG; Cooper TB; Walls D; Carroll P; Simpson MT; Hess RG; Stanley AW; MacLean WA Ala Med; 1987 Mar; 56(9):20-3. PubMed ID: 2953218 [No Abstract] [Full Text] [Related]
10. Enhanced platelet function in acute myocardial infarction is attenuated by streptokinase treatment. Sylvén C; Karlberg KE; Chen J; Hagerman I; Egberg N; Bergström K J Intern Med; 1992 Jun; 231(6):595-600. PubMed ID: 1535649 [TBL] [Abstract][Full Text] [Related]
11. Blood viscosity and platelet function in thrombolytic therapy of acute myocardial infarction. Hoffmann JJ Eur Heart J; 1990 Aug; 11 Suppl F():29-35. PubMed ID: 2121489 [TBL] [Abstract][Full Text] [Related]